PCOL 838b Exam 1 (2025/2026) – 65 Verified Questions & Answers | Immunology, Hypersensitivity, Hematology, Coagulation & Pulmonary Pharmacology

This high-quality exam guide for PCOL 838b (Immunopharmacology) includes 65 fully answered and verified questions from the 2025/2026 academic session, all graded A+. It provides concise yet comprehensive responses to key immunological and pharmacological topics, including MHC Class I and II mechanisms, humoral and cell-mediated immunity, hypersensitivity types (I–IV), autoimmune disorders (e.g., lupus, rheumatoid arthritis), and primary immunodeficiencies (e.g., X-linked agammaglobulinemia, DiGeorge syndrome). It also thoroughly addresses hematopoiesis, blood cell markers, key diagnostic tests (e.g., NBT, ferritin, transferrin, MCV), and the coagulation cascade—covering initiation, amplification, and propagation phases, along with regulatory proteins like antithrombin and protein C. Pulmonary pathologies such as asthma, emphysema, pulmonary fibrosis, and bronchitis are explained alongside pharmacological treatments including corticosteroids, beta-2 agonists, leukotriene receptor antagonists, and anti-cholinergics. This document is especially relevant for students enrolled in: – Pharmacology – Medicine (MD, MBBS) – Biomedical Sciences – Immunology – Pathology – Nursing (BSN, MSN) – Physician Assistant (PA) – Clinical Laboratory Sciences – Pharmacy (PharmD) It is an ideal resource for both course preparation and standardized exams involving immunopharmacological content, such as USMLE, NCLEX, or graduate-level assessments. The questions are formatted for rapid review and understanding, making it perfect for last-minute exam revision or in-depth study sessions. Keywords: MHC I, MHC II, CD4, CD8, B cells, T cells, isotype switching, somatic recombination, hypersensitivity, autoimmune disease, X-linked agammaglobulinemia, DiGeorge syndrome, lupus, rheumatoid arthritis, immunodeficiency, hematopoiesis, ferritin, transferrin, coagulation cascade, thrombin, antithrombin, asthma, COPD, bronchitis, pulmonary fibrosis, corticosteroids, beta-2 agonists, leukotriene antagonists